SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
American Society of Clinical Oncology Presentations Highlight Preliminary Results of Studies With Millennium: The Takeda Oncology Company's MLN9708, First Oral Proteasome Inhibitor in Clinical Trials in Multiple Myeloma